What do systematic reviews say?

Summary of findings: Decentralised vs centralised follow‐up

• Follow‐up strategies for women treated for early breast cancer 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 356 participants
  High

Intervention not reported

• Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 16 participants
  Very low

Honey vs standard dressing

The review found no eligible studies for this question.

• Honey as a topical treatment for wounds 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Honey vs silver sulfadiazine

The review found no eligible studies for this question.

• Honey as a topical treatment for wounds 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Honey vs standard dressing

The review found no eligible studies for this question.

• Honey as a topical treatment for wounds 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy‐naive advanced non‐small cell lung cancer 2014 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 1801 participants
  Low

Corticosteroids vs modafinil

• Corticosteroids for the management of cancer‐related fatigue in adults with advanced cancer 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 73 participants
  Very low

Ultrasound‐assisted catheter‐directed thrombolysis plus standard intravenous heparinisation vs standard intravenous heparinisation

• Catheter‐directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute… 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 59 participants
  GRADE not reported

Short‐acting inhaled beta‐2 agonists vs short‐acting inhaled muscarinic antagonists

The review found no eligible studies for this question.

• Short‐acting inhaled bronchodilators for cystic fibrosis 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Short‐acting inhaled beta‐2 agonists vs placebo

The review found no eligible studies for this question.

• Short‐acting inhaled bronchodilators for cystic fibrosis 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Short‐acting inhaled muscarinic antagonists vs placebo

The review found no eligible studies for this question.

• Short‐acting inhaled bronchodilators for cystic fibrosis 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: Single vs combination intravenous anti‐pseudomonal antibiotic therapy

The review found no eligible studies for this question.

• Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Sclerotherapy plus compression vs sclerotherapy (any sclerosant)

• Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 93 participants
  Low

Intervention not reported

• Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma 2021 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 294 participants
  Very low

Attention training vs control

• Cognitive rehabilitation for attention deficits following stroke 2019 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 99 participants
  Very low
• Cognitive rehabilitation for attention deficits following stroke 2019 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 103 participants
  Low

Taxane followed by anthracyclines vs anthracyclines followed by taxane

• Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 20 participants
  Moderate

Preoperative radiotherapy vs surgery

• Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma 2018 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 3211 participants
  Low

Intervention not reported

• Probiotics for people with hepatic encephalopathy 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 69 participants
  Very low

Intervention not reported

• Probiotics for people with hepatic encephalopathy 2017 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 115 participants
  Low

Virtual reality vs passive intervention (short term)

• Virtual reality for rehabilitation in Parkinson's disease 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 24 participants
  Very low